Current guidelines and recommendations for the management of skin and soft tissue infections

Current Opinion in Infectious Diseases

Volumn 29, Issue 2, 2016, Pages 131-138

  Montravers, Philippe ^a,b   Snauwaert, Aurelie ^a   Welsch, Camille ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cellulitis; Guidelines; Methicillin resistant Staphylococcus aureus; Necrotizing infections; Skin and soft tissue infections

Indexed keywords

ANTIBIOTIC AGENT; ANTITOXIN; IMMUNOGLOBULIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; HUMAN; HYPERBARIC OXYGEN; IMMUNOCOMPROMIZED PATIENT; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEUTROPENIA; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT DURATION; DEBRIDEMENT; DERMATOMYCOSES; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

ANTI-INFECTIVE AGENTS; DEBRIDEMENT; DERMATOMYCOSES; HUMANS; PRACTICE GUIDELINES AS TOPIC; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS;

EID: 84960092010     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000242     Document Type: Review

References (17)

1. May AK. Skin and soft tissue infections: the new surgical infection society guidelines. Surg Infect 2011;12:179-184.
2. Treatment guide for skin and soft tissue infections. Spanish Chemotherapy Society, Spanish Internal Medicine Society, Spanish Association of Surgeons. Rev Esp Quimioter 2006;19:378-394.
3. May AK, Stafford RE, Bulger EM, et al. Treatment of complicated skin and soft tissue infections. Surg infect 2009;10:467-499.
4. Esposito S, Bassetti M, Borre S, et al. Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy. J Chemother 2011;23:251-262.
5. Chapter 2-5-3a. Anaerobic infections (individual fields): skin and soft tissue infections. J Infect Chemother 2011;17(Suppl 1):72-76.
6. Sartelli M, Malangoni MA, May AK, et al. World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 2014;9:57. The World Society of Emergency Surgery guidelines are a good summary of the major issues that surgeons, emergency physicians, and intensivists have to address on a daily practice for patients suspected of having slin and soft tissue infections.
7. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014;59:e10-e52. Infectious Diseases Society of America guidelines give the largest and most recent approach for the treatment of skin and soft tissue infections.
8. Gould FK, Brindle R, Chadwick PR, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009;63:849-861.
9. Pan A, Cauda R, Concia E, et al. Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections. Int J Infect Dis 2010;14(Suppl 4):S39-S53.
10. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-292.
11. Mensa J, Soriano A, Llinares P, et al. Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus. Rev Esp Quimioter 2013;26(Suppl 1):1-84.
12. US Department of Health and Human Services. Food and Drug Administration. Guidance for industry-acute bacterial skin and skin structure infections: developing drugs for treatment. In: Edited by Center for Drug Evaluation and Research 2013. http://www.fda.gov/Drugs/Guidance-ComplianceRegulatoryInformation/Guidances/default.htm. [Accessed 17 December 2015]
13. Marwick C, Broomhall J, McCowan C, et al. Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother 2011;66:387-397.
14. Wong CH, Khin LW, Heng KS, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32:1535-1541.
15. Bronchard R, de Vaumas C, Lasocki S, et al. Vacuum-assisted closure in the treatment of perineal necrotizing skin and soft tissue infections. Intens Care Med 2008;34:1345-1347.
16. Montravers P, Bassetti M, Dupont H, et al. Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies. J Antimicrob Chemother 2013;68(Suppl 2):ii15-ii24.
17. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-e55.